|
US4179338A
(en)
|
1977-09-19 |
1979-12-18 |
Gordon Maurice R |
Microbiological medium suitable for sterilization by ionizing radiation
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
WO1981001145A1
(en)
|
1979-10-18 |
1981-04-30 |
Univ Illinois |
Hydrolytic enzyme-activatible pro-drugs
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
EP0272253A4
(en)
|
1986-03-07 |
1990-02-05 |
Massachusetts Inst Technology |
METHOD FOR IMPROVING GLYCOPROTE INSTABILITY.
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
GB8705477D0
(en)
|
1987-03-09 |
1987-04-15 |
Carlton Med Prod |
Drug delivery systems
|
|
AU600575B2
(en)
|
1987-03-18 |
1990-08-16 |
Sb2, Inc. |
Altered antibodies
|
|
US4975278A
(en)
|
1988-02-26 |
1990-12-04 |
Bristol-Myers Company |
Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
|
|
US5204244A
(en)
|
1987-10-27 |
1993-04-20 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
|
US5202238A
(en)
|
1987-10-27 |
1993-04-13 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
EP1005870B1
(en)
|
1992-11-13 |
2009-01-21 |
Biogen Idec Inc. |
Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
CA2156725A1
(en)
|
1993-02-22 |
1994-09-01 |
Warren S. Pear |
Production of high titer helper-free retroviruses by transient transfection
|
|
FR2712812B1
(fr)
|
1993-11-23 |
1996-02-09 |
Centre Nat Rech Scient |
Composition pour la production de produits thérapeutiques in vivo.
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
WO1997010354A1
(fr)
|
1995-09-11 |
1997-03-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Anticorps de la chaine alpha du recepteur de l'interleukine 5 humaine
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
ES2203782T3
(es)
|
1996-01-17 |
2004-04-16 |
Imperial College Innovations Limited |
Inmunoterapia que utiliza linfocitos t citotoxicos (ctl).
|
|
EP1194542A1
(en)
|
1999-03-02 |
2002-04-10 |
Ludwig Institute For Cancer Research |
Cloning of cdna of mage's 5,8,9 and 11 and their uses in diagnosis of cancer
|
|
MX340559B
(es)
|
1999-12-06 |
2016-07-14 |
Board Of Trustees Of The Univ Of Illinois |
Proteinas de tcr de alta afinidad y metodos.
|
|
EP1242049A4
(en)
*
|
1999-12-13 |
2005-01-05 |
Epimmune Inc |
VACCINE COMPOSITIONS AND ANTIGEN PEPTIDES ASSOCIATED WITH CLASS I HLA-A2 TUMOR
|
|
CA2417570C
(en)
*
|
2000-07-31 |
2010-12-07 |
Kyogo Itoh |
Tumor-specific t cell activation by peptide antigens
|
|
WO2002072627A2
(en)
|
2001-03-09 |
2002-09-19 |
Callistogen Ag |
Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
|
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
|
AU2003226141A1
(en)
|
2002-03-27 |
2003-10-13 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Method for treating cancer in humans
|
|
DE10225139A1
(de)
|
2002-05-29 |
2004-02-26 |
Immatics Biotechnologies Gmbh |
Verfahren zur Identifizierung von immunreaktiven Peptiden
|
|
ES2327229T3
(es)
|
2002-11-09 |
2009-10-27 |
Immunocore Ltd. |
Presentacion del receptor de linfocitos t.
|
|
GB0308731D0
(en)
|
2003-04-15 |
2003-05-21 |
Anticancer Therapeutic Inv Sa |
Method of radiotherapy
|
|
US7807392B1
(en)
|
2003-09-15 |
2010-10-05 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
WO2005076009A2
(en)
|
2004-01-28 |
2005-08-18 |
Immatics Biotechnologies Gmbh |
Method for identifying and quantifying of tumour-associated peptides
|
|
JP2008532014A
(ja)
*
|
2005-02-24 |
2008-08-14 |
セマインズ，インコーポレイティド |
生物試料を分類するための組成物及び方法
|
|
US9963510B2
(en)
|
2005-04-15 |
2018-05-08 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
ATE461215T1
(de)
|
2005-09-05 |
2010-04-15 |
Immatics Biotechnologies Gmbh |
Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden
|
|
KR101130597B1
(ko)
|
2005-09-13 |
2012-04-02 |
다카라 바이오 가부시키가이샤 |
Ｔ 세포 리셉터 및 그 리셉터를 코드하는 핵산
|
|
WO2008053573A1
(fr)
|
2006-10-30 |
2008-05-08 |
National University Corporation Hokkaido University |
Remède pour néoplasme malin
|
|
KR101351195B1
(ko)
|
2007-07-27 |
2014-01-14 |
이매틱스 바이오테크놀로지스 게엠베하 |
면역 치료를 위한 새로운 면역원성 에피톱
|
|
ES2672769T3
(es)
|
2007-08-29 |
2018-06-18 |
Sanofi |
Anticuerpos anti-CXCR5 humanizados, derivados de los mismos y sus usos
|
|
DK3059246T3
(en)
|
2007-09-26 |
2018-10-01 |
Chugai Pharmaceutical Co Ltd |
Modified constant region of an antibody
|
|
DK2288700T3
(en)
|
2008-05-09 |
2017-05-22 |
Agency Science Tech & Res |
HBV EPITOP-REACTIVE EXOGEN T-CELL RECEPTOR (TCR) AND APPLICATIONS THEREOF
|
|
PL2119726T5
(pl)
|
2008-05-14 |
2018-04-30 |
Immatics Biotechnologies Gmbh |
Nowe i silne peptydy MHC klasy II pochodzące z surwiwiny i neurokanu
|
|
TW201008574A
(en)
*
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
|
WO2010037395A2
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
|
US9840695B2
(en)
|
2009-04-28 |
2017-12-12 |
Agriculture Victoria Services Pty Ltd |
Plant technology
|
|
EP2258719A1
(en)
|
2009-05-19 |
2010-12-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Multiple target T cell receptor
|
|
GB0917094D0
(en)
|
2009-09-29 |
2009-11-11 |
Ucl Biomedica Plc |
T-cell receptor
|
|
US10464987B2
(en)
|
2009-10-06 |
2019-11-05 |
Abbvie Inc. |
Human single-chain T cell receptors
|
|
WO2011066265A1
(en)
*
|
2009-11-25 |
2011-06-03 |
Ludwig Institute For Cancer Research Ltd. |
Cancer testis antigens as biomarkers in non-small cell lung cancer
|
|
GB201004551D0
(en)
*
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
US9114100B2
(en)
|
2010-05-17 |
2015-08-25 |
Duke University |
Methods of treatment using ex vivo expansion of cord blood T cells
|
|
CN101870725B
(zh)
*
|
2010-06-29 |
2012-06-27 |
郑州大学 |
Mage-4抗肿瘤ctl表位肽及其应用
|
|
BR112013006718B1
(pt)
|
2010-09-20 |
2021-12-07 |
Tron - Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberguniversität Mainz Gemeinnutzige Gmbh |
Receptor de células t com especificidade para ny-eso-1, composição farmacêutica compreendendo o mesmo e uso do mesmo
|
|
TWI588156B
(zh)
|
2011-03-28 |
2017-06-21 |
賽諾菲公司 |
具有交叉結合區定向之雙重可變區類抗體結合蛋白
|
|
WO2013026837A1
(en)
|
2011-08-23 |
2013-02-28 |
Roche Glycart Ag |
Bispecific t cell activating antigen binding molecules
|
|
AU2012302778B2
(en)
*
|
2011-08-31 |
2016-11-24 |
Mie University |
Vaccine preparation for cancer treatment
|
|
WO2013057596A1
(en)
|
2011-10-21 |
2013-04-25 |
Atena Srl |
Anatomic cushion accumulator for thermal treatment with heat or cold
|
|
EP2660250B1
(en)
|
2012-05-02 |
2018-11-14 |
Deutsches Rheuma-Forschungszentrum Berlin |
Tcr transgenic mouse model for immune disease
|
|
CN104684926B
(zh)
|
2012-07-27 |
2022-04-08 |
伊利诺伊州大学理事会 |
工程化t细胞受体
|
|
ES2774931T3
(es)
|
2012-09-14 |
2020-07-23 |
Us Health |
Receptores de linfocitos t que reconocen MAGE-A3 restringida al MHC de clase II
|
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
|
GB2508414A
(en)
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
EP2968520B1
(en)
|
2013-03-14 |
2021-05-12 |
MacroGenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor
|
|
EP2970484B2
(en)
|
2013-03-15 |
2022-09-21 |
Amgen Inc. |
Heterodimeric bispecific antibodies
|
|
WO2014153470A2
(en)
|
2013-03-21 |
2014-09-25 |
Sangamo Biosciences, Inc. |
Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases
|
|
CA2916960C
(en)
|
2013-06-26 |
2022-12-06 |
Guangzhou Xiangxue Pharmaceutical Co. Ltd |
High-stability t-cell receptor and preparation method and application thereof
|
|
TWI714869B
(zh)
|
2013-08-05 |
2021-01-01 |
德商伊瑪提克斯生物科技有限公司 |
新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物
|
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
US11203783B2
(en)
|
2013-11-21 |
2021-12-21 |
Repertoire Genesis Incorporation |
T cell receptor and B cell receptor repertoire analysis system, and use of same in treatment and diagnosis
|
|
KR102225489B1
(ko)
|
2013-12-17 |
2021-03-10 |
제넨테크, 인크. |
항-cd3 항체 및 이의 사용 방법
|
|
US10202640B2
(en)
|
2014-05-07 |
2019-02-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing
|
|
GB201408255D0
(en)
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
|
WO2015172843A1
(en)
*
|
2014-05-16 |
2015-11-19 |
Biontech Diagnostics Gmbh |
Methods and kits for the diagnosis of cancer
|
|
EP2985294A1
(en)
|
2014-08-14 |
2016-02-17 |
Deutsches Krebsforschungszentrum |
Recombinant antibody molecule and its use for target cell restricted T cell activation
|
|
CA2963364A1
(en)
*
|
2014-10-02 |
2016-04-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of isolating t cells having antigenic specificity for a cancer-specific mutation
|
|
WO2016071343A1
(en)
|
2014-11-03 |
2016-05-12 |
Immures S.R.L. |
T cell receptors
|
|
GB201423361D0
(en)
|
2014-12-30 |
2015-02-11 |
Immatics Biotechnologies Gmbh |
Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides
|
|
MY191964A
(en)
|
2015-01-23 |
2022-07-21 |
Sanofi Sa |
Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123
|
|
EP3067366A1
(en)
|
2015-03-13 |
2016-09-14 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201506642D0
(en)
|
2015-04-20 |
2015-06-03 |
Ucl Business Plc |
T cell receptor
|
|
MX2017014822A
(es)
|
2015-05-18 |
2018-04-30 |
Tcr2 Therapeutics Inc |
Composiciones y métodos para la reprogramación del tcr con proteínas de fusión.
|
|
EP3095792A1
(en)
|
2015-05-19 |
2016-11-23 |
Klinikum rechts der Isar der Technischen Universität München |
T cell receptor with specificity for myeloperoxidase peptide and uses thereof
|
|
CN105219714A
(zh)
*
|
2015-10-20 |
2016-01-06 |
上海隆耀生物科技有限公司 |
一种用于激活肺癌特异性免疫反应的试剂盒
|
|
CN105219719A
(zh)
*
|
2015-10-20 |
2016-01-06 |
上海隆耀生物科技有限公司 |
一种用于激活卵巢癌特异性免疫反应的试剂盒
|
|
WO2017070608A1
(en)
|
2015-10-23 |
2017-04-27 |
Eureka Therapeutics, Inc. |
Antibody/t-cell receptor chimeric constructs and uses thereof
|
|
GB201522592D0
(en)
|
2015-12-22 |
2016-02-03 |
Immunocore Ltd |
T cell receptors
|
|
CN116731156A
(zh)
*
|
2016-03-16 |
2023-09-12 |
伊玛提克斯生物技术有限公司 |
用于癌症免疫治疗的转染t细胞和t细胞受体
|
|
GB201604492D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Transfected t-cells and t-cell receptors for use in immunotherapy against cancers
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
WO2017180587A2
(en)
|
2016-04-11 |
2017-10-19 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
|
CA3032498A1
(en)
|
2016-08-02 |
2018-02-08 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
WO2018026018A1
(ja)
|
2016-08-05 |
2018-02-08 |
国立大学法人東北大学 |
Ｔ細胞受容体の認識機構を用いたがん又は感染症の治療及び診断
|
|
GB201617716D0
(en)
|
2016-10-19 |
2016-11-30 |
Ucl Business Plc |
Cell
|
|
GB201617714D0
(en)
|
2016-10-19 |
2016-11-30 |
Ucl Business Plc |
T Cell receptor
|
|
DE102016121899A1
(de)
|
2016-11-15 |
2018-05-17 |
Immatics Biotechnologies Gmbh |
Verfahren zur Herstellung von elektrokompetenten Hefezellen und Verfahren zur Verwendung dieser Zellen
|
|
DE102016123893A1
(de)
|
2016-12-08 |
2018-06-14 |
Immatics Biotechnologies Gmbh |
T-Zellrezeptoren mit verbesserter Bindung
|
|
BR112019028280A2
(pt)
|
2017-07-04 |
2020-07-14 |
Curevac Ag |
moléculas de ácido nucleico
|
|
US20190016802A1
(en)
|
2017-07-14 |
2019-01-17 |
Immatics Biotechnologies Gmbh |
Dual specificity polypeptide molecule
|
|
MX2020001879A
(es)
|
2017-08-18 |
2020-07-29 |
Gritstone Oncology Inc |
Proteínas de fijación al antígeno que se dirigen a antígenos compartidos.
|
|
WO2019051001A1
(en)
|
2017-09-06 |
2019-03-14 |
California Institute Of Technology |
SIGNALING AND BIFUNCTIONAL RECEPTORS HAVING ANTIGENS (SABR)
|
|
US11866731B2
(en)
|
2017-11-10 |
2024-01-09 |
Chineo Medical Technology Co., Ltd |
Modified immune cells and uses thereof
|
|
DE102017127984B4
(de)
|
2017-11-27 |
2019-12-05 |
Immatics US, Inc. |
Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
|
|
JP2021508475A
(ja)
|
2017-12-28 |
2021-03-11 |
グリットストーン オンコロジー インコーポレイテッド |
共有抗原を標的とする抗原結合タンパク質
|
|
DE102018100967B4
(de)
|
2018-01-17 |
2019-08-14 |
Immatics US, Inc. |
Verfahren zur feststellung der wirksamkeit von viralen vektoren
|
|
US20210041435A1
(en)
|
2018-01-31 |
2021-02-11 |
Tohoku University |
Method for regulating antigen-specific mhc expression
|
|
US11464800B2
(en)
|
2018-02-09 |
2022-10-11 |
Immatics US, Inc. |
Methods for manufacturing T cells
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
SI3773689T1
(sl)
|
2018-04-11 |
2023-02-28 |
Enterome S.A. |
Antigenski peptidi za preprečevanje in zdravljenje raka
|
|
JP2021522835A
(ja)
|
2018-05-14 |
2021-09-02 |
イムノコア リミテッド |
二機能性結合ポリペプチド
|
|
CA3100775A1
(en)
|
2018-05-18 |
2019-11-21 |
Children's National Medical Center |
Improved targeted t-cell therapy
|
|
TW202000907A
(zh)
|
2018-05-23 |
2020-01-01 |
美商葛利史東腫瘤科技公司 |
共有抗原
|
|
EP3802614A1
(en)
|
2018-06-04 |
2021-04-14 |
Apo-T B.V. |
Methods and means for attracting immune effector cells to tumor cells
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
HUE065436T2
(hu)
|
2019-01-17 |
2024-06-28 |
Immunocore Ltd |
Kiszerelések
|
|
GB201901306D0
(en)
|
2019-01-30 |
2019-03-20 |
Immunocore Ltd |
Multi-domain binding molecules
|
|
CN114375301B
(zh)
|
2019-05-08 |
2025-08-05 |
基因医疗免疫疗法有限责任公司 |
工程改造的t细胞
|
|
KR20220010743A
(ko)
|
2019-05-21 |
2022-01-26 |
노파르티스 아게 |
Bcma에 대한 삼중특이적 결합 분자 및 이의 용도
|
|
EP3986938A4
(en)
|
2019-06-18 |
2023-06-28 |
Regeneron Pharmaceuticals, Inc. |
Mage-a4 t cell receptors and methods of use thereof
|
|
GB201911286D0
(en)
|
2019-08-07 |
2019-09-18 |
Ucl Business Plc |
Method
|
|
WO2021073624A1
(zh)
|
2019-10-17 |
2021-04-22 |
北京门罗生物科技有限公司 |
用于免疫治疗的嵌合抗原受体、制备方法及其应用
|
|
JP2023531385A
(ja)
|
2020-06-04 |
2023-07-24 |
セーフシール－システムズ |
セルフシール容器
|
|
IL308258A
(en)
|
2021-05-05 |
2024-01-01 |
Immatics Biotechnologies Gmbh |
Bma031 antigen binding polypeptides
|